Asset Management Corp Gilead Sciences, Inc. Transaction History

Asset Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$60.0 - $68.46 $191,700 - $218,729	-3,195 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$56.65 - $64.55 $355,422 - $404,986	-6,274 Reduced 66.26%	3,195 $202,000
Q3 2020 Oct 26, 2020	SELL	$62.1 - $78.08 $10,743 - $13,507	-173 Reduced 1.79%	9,469 $598,000
Q2 2020 Jul 21, 2020	BUY	$72.34 - $84.0 $453,716 - $526,848	6,272 Added 186.11%	9,642 $742,000
Q1 2020 Apr 14, 2020	BUY	$62.63 - $80.22 $211,063 - $270,341	3,370 New	3,370 $252,000

1,924

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Asset Management Corp , based on Form 13F filings with the SEC.

Stay updated on Asset Management Corp with notifications on news.